{"title":"Exploring the Connection of Otitis Media with Effusion and Allergic Rhinitis: A Systematic Review.","authors":"Álef Lamark Alves Bezerra, Gabriela Brill Ney, Fayez Bahmad","doi":"10.1055/s-0046-1819713","DOIUrl":"10.1055/s-0046-1819713","url":null,"abstract":"<p><strong>Introduction: </strong>Otitis media with effusion (OME) is characterized by fluid accumulation in the middle ear behind an intact eardrum, often coexisting with allergic rhinitis, an inflammatory nasal condition causing symptoms such as nasal obstruction. Both conditions are prevalent in children and may share immune-mediated mechanisms linked to the <i>unified airway</i> concept. Previous studies suggest allergic rhinitis contributes to Eustachian-tube dysfunction and middle-ear effusion persistence, but the understanding of their interplay remains incomplete.</p><p><strong>Objective: </strong>To evaluate the association between allergic rhinitis and OME, identifying risk factors, diagnostic methods, and potential therapeutic strategies.</p><p><strong>Methods: </strong>The current systematic review adhered to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We conducted a search on the PubMed database using the Medical Subject Headings (MeSH) otitis media with effusion and rhinitis, Allergic; we identified 181 articles, which were narrowed to 15 based on the inclusion criteria.</p><p><strong>Results: </strong>Most studies revealed a significant association between allergic rhinitis and OME, particularly in children. Diagnostic methods such as intradermal dilution testing showed higher sensitivity than skin prick tests. Immunotherapy effectively addressed both conditions, even in cases with negative prick tests. Reduced micro ribonucleic acid (microRNA) 320e (miR-320e) expression was noted in allergic OME, suggesting potential as a biomarker. Surgical intervention provided symptom relief, but addressing underlying allergies proved essential. The studies were predominantly from China (20%) and the United States (13.3%).</p><p><strong>Conclusion: </strong>Allergic rhinitis plays a crucial role in OME development and symptom exacerbation. Immunotherapy may serve as a preventive strategy, emphasizing the need for clinical guidelines. The present study bridges gaps in regional medical literature, offering valuable insights for clinicians and highlighting the need for further research to optimize pediatric care outcomes.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13680057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149227918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maira I S Stangler, José F Lubianca Neto, Marcelo N Lubianca
{"title":"Evaluation of the Analgesic Efficacy of Preemptive Dipyrone in the Postoperative Period of Adenotonsillectomy in Children: A Randomized Clinical Trial.","authors":"Maira I S Stangler, José F Lubianca Neto, Marcelo N Lubianca","doi":"10.1055/s-0046-1827208","DOIUrl":"10.1055/s-0046-1827208","url":null,"abstract":"<p><strong>Introduction: </strong>Dipyrone is one of the most commonly used postoperative analgesics. However, there are only two randomized, placebo-controlled clinical trials evaluating its effect in pediatric tonsillectomies.</p><p><strong>Objective: </strong>To compare postoperative pain outcomes following the use of pre-incisional dipyrone or placebo in pediatric adenotonsillectomy.</p><p><strong>Methods: </strong>This was a randomized, double-blind, parallel, placebo-controlled clinical trial in children aged 4 to 14 years who underwent adenotonsillectomy. A total of 76 participants were randomized into the intervention/dipyrone group (n = 39) and the placebo group (n = 37). All received either dipyrone or saline solution (placebo) at one of two time points: before the surgical incision or at the end of surgery.</p><p><strong>Results: </strong>The mean age was 6.8 years and weight was 32.1 kg. In the intervention group, vital signs were normal and only 7.7% experienced emesis, compared with 8.1% in the placebo group. Food intake was anticipated by 1,1 hours in the dipyrone group. Pain was controlled in at least 77.6% of participants at all evaluated time points (H0, H1, H3, and H6) in both groups. At H3, pain was controlled in 54.2% of the intervention group compared with 45.8% in the placebo group. In addition, the dipyrone group demonstrated a tendency toward a lower need for opioids in H1 and H3, reducing opioid administration by 50% and 52.63%, respectively, compared with placebo.</p><p><strong>Conclusion: </strong>A trend toward pain relief, earlier diet acceptance, and a lower need for opioids was observed in the group that received preemptive dipyrone. The results did not reach statistical significance, likely due to a type II error.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13668381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149193173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samer Ahmed Ibrahim, Tamer Shoukry Sobhy, Sara Ashraf Shoeib, Ahmed Abdelmoneim Teaima
{"title":"Comparison of the Outcomes of Lateral Wall, Perimodiolar, and Midscala Electrodes in Cochlear Implantation Surgery: A Meta-Analysis.","authors":"Samer Ahmed Ibrahim, Tamer Shoukry Sobhy, Sara Ashraf Shoeib, Ahmed Abdelmoneim Teaima","doi":"10.1055/s-0046-1820087","DOIUrl":"10.1055/s-0046-1820087","url":null,"abstract":"<p><strong>Introduction: </strong>Cochlear implant (CI) is the standard of care for most cases of severe-to-profound hearing loss. Different electrodes are available for CI.</p><p><strong>Objective: </strong>To compare the lateral wall, midscala, and perimodiolar electrodes in CI surgery in terms of trauma to the cochlea and hearing preservation (if there is residual hearing).</p><p><strong>Data synthesis: </strong>We performed a comprehensive search on the PubMed/MEDLINE, Scopus, Web of Science, and Cochrane Library databases in June 2022 for articles in the literature published until this year. We included studies published in English, involving human subjects, and regarding the types of electrodes in CI surgery, and we excluded laboratory and opinion studies. The current review followed the guidelines of the 2009 Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. We found 21 studies; the hearing preservation rates with each electrode were as follows: lateral wall electrode - 53%; perimodiolar electrode - 35%; and midscala electrode - 58%. The lateral wall and midscala electrodes presented better preservation of residual hearing than the perimodiolar electrode. The rates of cochlear trauma with each electrode were as follows: lateral wall electrode - 61%; perimodiolar electrode - 29%; and midscala electrode - 16%.</p><p><strong>Conclusion: </strong>The rates of preservation of functional residual hearing in CI are higher in lateral wall and midscala electrodes than in perimodiolar electrodes.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-9"},"PeriodicalIF":1.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13668382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149193135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of Intratonsillar Steroid Injection for Reducing Palatine Tonsil Size in Tonsillar Hypertrophy: A Randomized Controlled Trial.","authors":"Arunrat Dumkliang, Ekachai Dumkliang","doi":"10.1055/a-2798-2798","DOIUrl":"10.1055/a-2798-2798","url":null,"abstract":"<p><strong>Introduction: </strong>Tonsillectomy is a common treatment for obstructive sleep apnea (OSA) and remains one of the most frequently performed surgical procedures worldwide. However, postoperative morbidity is a persistent clinical concern. Intratonsillar steroid injection may offer a non-surgical alternative by reducing the size of hypertrophic palatine tonsils.</p><p><strong>Objective: </strong>this study aims to evaluate the efficacy and safety of intratonsillar steroid injections compared to intralesional injections of normal saline solution (NSS) in tonsillar hypertrophy.</p><p><strong>Study design: </strong>Prospective study (Randomized control trial).</p><p><strong>Materials and methods: </strong>In this randomized controlled trial, 19 participants (38 tonsils) were assigned to four groups receiving intratonsillar injections of triamcinolone acetonide (TA, 40 mg/mL, 1 mL) or NSS (1 mL). Nine participants received multiple injections at weeks 0, 4, and 8; ten received a single injection. Tonsil size was measured before each injection to assess the clinical efficacy of reducing palatine tonsil size.</p><p><strong>Results: </strong>There was a significant reduction in tonsil size after steroid injections, with a statistically significant difference observed only in the multiple steroid injection group (p-value = 0.04). The steroid injection group experienced slightly more pain compared to the NSS injection group, however, no severe adverse effects were observed in either group.</p><p><strong>Conclusion: </strong>Intratonsillar steroid injections effectively reduced the size of palatine tonsils compared with NSS injections. Repeated steroid injections were more effective than a single injection.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-6"},"PeriodicalIF":1.1,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149080651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laura Franco Chiriboga, Karolina Pessote Sideri, Jonathan Grassi, Elaine Soares Monteiro Pinto, Luis Miguel Chiriboga Arteta
{"title":"8,888 Newborns Over One Year: Evaluation of a Universal Neonatal Hearing Screening Program.","authors":"Laura Franco Chiriboga, Karolina Pessote Sideri, Jonathan Grassi, Elaine Soares Monteiro Pinto, Luis Miguel Chiriboga Arteta","doi":"10.1055/a-2804-5197","DOIUrl":"10.1055/a-2804-5197","url":null,"abstract":"<p><strong>Introduction: </strong>Universal Newborn Hearing Screening is essential for early detection of hearing loss, enabling prompt interventions and improving child development.</p><p><strong>Objective: </strong>To analyze the outcomes of a universal neonatal hearing screening program.</p><p><strong>Methods: </strong>Retrospective descriptive study analyzing the results of neonatal hearing screening. The inclusion criterion was birth at or transfer to the hospital between January and December 2023. The research was approved by the Research Ethics Committee, under number 5.227.720/2022.</p><p><strong>Results: </strong>8,828 (99.32% of total sample) underwent screening, with 7,846 having no risk factors for hearing loss and 982 identified with risk factors for hearing loss. Among the 60 newborns who were not screened, 7 (0.08%) were transferred to other hospitals before undergoing the universal neonatal hearing screening, 50 (0.56%) passed away, and 3 (0.03%) were lost to follow-up and did not undergo the screening. For the TEOAE and aABR tests, the variables sex, type of healthcare service, and birth weight had a significant effect on increasing the likelihood of test failures.</p><p><strong>Conclusion: </strong>The outcomes of one year of the UNHS service were assessed, revealing a coverage rate of 99.96%. The service meets the quality indicators recommended by the guidelines, except for the percentage of referrals for diagnosis. Although challenges remain and new goals are yet to be achieved, the importance of conducting further research is recognized to monitor the auditory development of infants throughout life, especially those with risk factors for hearing loss.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 4","pages":"1-10"},"PeriodicalIF":1.1,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13623491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149080695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muhammad Umar Farooq, Priya Sunil Patel, Gursahib Singh Bal, Faisal Javed
{"title":"Management of Sudden Sensorineural Hearing Loss among General Practitioners in the United Kingdom: A Cross-Sectional Survey Study.","authors":"Muhammad Umar Farooq, Priya Sunil Patel, Gursahib Singh Bal, Faisal Javed","doi":"10.1055/a-2804-6442","DOIUrl":"10.1055/a-2804-6442","url":null,"abstract":"<p><strong>Objective: </strong>To assess how general practitioners (GPs) in the United Kingdom recognise, investigate, and manage sudden sensorineural hearing loss (SSNHL), and to determine the extent to which their practice aligns with national guidance.</p><p><strong>Methods: </strong>A cross-sectional online survey was distributed between January and July 2025 to fully qualified GPs across the West Midlands. The questionnaire explored definitions used, diagnostic methods, management strategies, and familiarity with NICE and ENT UK recommendations.</p><p><strong>Results: </strong>Fifty GPs completed the survey. Although 84% attempted to distinguish conductive from sensorineural loss, only 56% regularly used tuning-fork tests. Urgent ENT referral was the most common initial step (68%), while only 18% initiated pharmacological therapy and 36% prescribed corticosteroids. Fewer than half were familiar with guideline content, yet 96% expressed a wish for additional training.</p><p><strong>Conclusion: </strong>SSNHL remains inconsistently recognized and managed in UK primary care. Improving GP confidence through targeted ENT education and streamlined referral pathways could substantially enhance early treatment and hearing outcomes.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-4"},"PeriodicalIF":1.1,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13577797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Adel Sadek, Maisara Mohamed Mahmoud Nasr, Ahmed Ali Mohamed Badawi, Tamer El Zaeem Esmaeel, Osama Galal Awad
{"title":"Antrochoanal Polyps: Nasal Anatomical and Pathological Variants as Risk Factors.","authors":"Ahmed Adel Sadek, Maisara Mohamed Mahmoud Nasr, Ahmed Ali Mohamed Badawi, Tamer El Zaeem Esmaeel, Osama Galal Awad","doi":"10.1055/s-0046-1827782","DOIUrl":"10.1055/s-0046-1827782","url":null,"abstract":"<p><strong>Introduction: </strong>The etiopathogenesis of antrochoanal polyp remans debatable.</p><p><strong>Objectives: </strong>To understand antrochoanal polyp development and to assess anatomical and pathological risk factors for its formation.</p><p><strong>Methods: </strong>This study included 40 subjects with antrochoanal polyp as a study group and a control group of 40 subjects with unilateral maxillary sinusitis. We compared the groups with respect to pathologic variants including the presence of thickened mucosal lining and antral cyst in the contralateral maxillary sinus. We also compared groups regarding anatomic variants such as nasal septal deviation, accessory maxillary sinus ostium, concha bullosa, paradoxical middle turbinate, and uncinate process insertion.</p><p><strong>Results: </strong>Antral cyst was found in the contralateral maxillary sinus was significantly more prevalent in subjects with antrochoanal polyp than in subjects with unilateral maxillary sinusitis. Additionally, nasal septal deviation toward the opposite side of the pathology was significantly more frequent in antrochoanal polyp group than in unilateral maxillary sinusitis group.</p><p><strong>Conclusion: </strong>Antrochoanal polyp is suggested to originate from an antral cyst in the maxillary sinus, which extends into the nasal cavity due to pressure changes within the maxillary sinus and nasal cavity. Changes in the nasal cavity airflow caused by nasal septal deviation toward the opposite side of the affected maxillary antrum may represent an important risk factor for antrochoanal polyp formation from a pre-existing antral cyst.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-5"},"PeriodicalIF":1.1,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13577798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Peyton Pinkus, Soroush Farsi, William D Strickland, Lauren Tong, John L Dornhoffer, Robert A Saadi
{"title":"Sensorineural Hearing Loss and Phosphodiesterase-5 Inhibitors: A Systematic Review.","authors":"Peyton Pinkus, Soroush Farsi, William D Strickland, Lauren Tong, John L Dornhoffer, Robert A Saadi","doi":"10.1055/s-0046-1820094","DOIUrl":"10.1055/s-0046-1820094","url":null,"abstract":"<p><strong>Introduction: </strong>Sudden sensorineural hearing loss (SSNHL) can significantly impact quality of life. Recent studies propose a link between the use of phosphodiesterase-5 inhibitors (PDE-5is) and SSNHL emergence.</p><p><strong>Objective: </strong>To clarify the relationship between PDE-5i use and the risk of SSNHL development.</p><p><strong>Data synthesis: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, two independent reviewers searched the PubMed, Embase, and Web of Science databases for articles up to December 2023 on hearing loss in PDE-5i users. Out of 190 abstracts initially identified, 6 met the inclusion criteria, totaling 54 patients aged between 37 and 62 years. One study involved 4 female participants, while the rest focused on 50 male patients. Sildenafil, vardenafil, and tadalafil were the most commonly used PDE-5is. All patients experienced sensorineural hearing loss, ranging from moderate to profound, with 4 patients (7%) noting tinnitus and 3 patients (5%), vertigo, in addition to the hearing loss. One patient experienced bilateral hearing loss 15 days after initiating sildenafil consumption. Corticosteroid therapy was the exclusive treatment in all cases. The long-term outcomes following the cessation of the medication were available in 7 cases: 4 patients (57%) had no improvement, 2 patients (29%) fully recovered, and 1 patient (14%) had incomplete resolution of the hearing loss.</p><p><strong>Conclusion: </strong>The current systematic review underscores the importance of monitoring hearing in PDE5i patients and advising them about the potential risk. Further research with larger samples and control groups is needed to establish a definitive causal link.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13577795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Ragab, Aymn Ali, Hossam Hussein, Abdeltwab Hassan, Shimaa Hassanein, Mohammad Noaman
{"title":"Radiological Feasibility of the Endoscopic Transnasal Prelacrimal Recess Approach.","authors":"Ahmed Ragab, Aymn Ali, Hossam Hussein, Abdeltwab Hassan, Shimaa Hassanein, Mohammad Noaman","doi":"10.1055/s-0046-1820089","DOIUrl":"10.1055/s-0046-1820089","url":null,"abstract":"<p><strong>Background: </strong>Prelacrimal recess (PLR) distance, medial wall thickness, and the internal angle of the pyriform notch (APN) have been suggested by various studies as assessment metrics to determine the feasibility and intraoperative difficulty of the transnasal prelacrimal recess approach (TPRA), with ethnic variations.</p><p><strong>Objective: </strong>To assess the computed tomography (CT) scan feasibility of endoscopic TPRA in healthy and diseased paranasal sinuses.</p><p><strong>Methods: </strong>Our sample consisted of 750 adults (1,500 sides) who had CT of the nose and paranasal sinuses (PNS) for various indications. The CT scans were analyzed to assess variations in the distance, thickness, and angle of the prelacrimal recess on both sides concerning different demographic parameters (age and gender). All parameters were grouped into low, median, or high radiological feasibility of TPRA.</p><p><strong>Results: </strong>There was no difference in feasibility parameters between 546 healthy PNS (72.8%) and 204 chronic rhinosinusitis cases (27.2%). Only 2.7% of the maxillary sinuses studied (1,500 sides) had high radiological feasibility, 53.1% had medium radiological feasibility, and 44.2% had low radiological feasibility for TPRA. Males and individuals younger than 30 years of age had a significantly greater distance and thinner walls, making the sinus more surgically accessible ( <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>The three parameters studied can be collectively applied to the preoperative assessment of patients subjected to TPRA with no effect of inflammation on accessibility parameters. Difficult accessibility can be anticipated in 42% of the population, so surgeons must have caution when practicing TPRA.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-9"},"PeriodicalIF":1.1,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13577800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Georgea Espindola Ribeiro, Maria Valéria Schmidt Goffi-Gomez, Ana Tereza de Matos Magalhães, Ana Cristina Hiromi Hoshino, Robinson Koji Tsuji
{"title":"Is the Presence of eCAP Intraoperatively a Predictor of Cochlear Implant Outcomes in Adults?","authors":"Georgea Espindola Ribeiro, Maria Valéria Schmidt Goffi-Gomez, Ana Tereza de Matos Magalhães, Ana Cristina Hiromi Hoshino, Robinson Koji Tsuji","doi":"10.1055/s-0046-1820088","DOIUrl":"10.1055/s-0046-1820088","url":null,"abstract":"<p><strong>Introduction: </strong>The electrically-evoked compound action potential (eCAP) is commonly used to assess the physiological integrity of the auditory nerve's first neuron in cochlear implant (CI) users. Electrical stimulation of this neuron is essential for transmitting auditory signals to the auditory cortex, enabling the recognition of acoustic cues.</p><p><strong>Objective: </strong>To determine whether the presence of intraoperative eCAP influences CI outcomes in adult individuals with pre- or postlingual deafness.</p><p><strong>Methods: </strong>The present retrospective cross-sectional study included adults with hearing loss of various etiologies who received a CI, either with pre- or postlingual deafness. Data on intraoperative eCAP results and speech recognition test outcomes after 12 months of consistent CI use were extracted from medical records.</p><p><strong>Results: </strong>Data from 121 ears were analyzed, comprising 101 individuals with post- and 20 with prelingual deafness. In the overall sample, 90.9% exhibited eCAP presence intraoperatively. In the prelingual group, eCAP was present in 100% of cases, while 89% of the postlingual group showed eCAP presence. Individuals with intraoperative eCAP demonstrated significantly better speech recognition performance compared with those without eCAP, in both open- and closed-set tests.</p><p><strong>Conclusion: </strong>In adults with postlingual deafness, 89% exhibited intraoperative eCAP, which correlated with significantly better speech recognition outcomes. In contrast, the prelingual group demonstrated intraoperative neural responses, but no significant correlation with speech recognition performance was observed.</p>","PeriodicalId":13731,"journal":{"name":"International Archives of Otorhinolaryngology","volume":"30 3","pages":"1-8"},"PeriodicalIF":1.1,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13569922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148955864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}